Odile Beyne-Rauzy

Odile Beyne-Rauzy

UNVERIFIED PROFILE

Are you Odile Beyne-Rauzy?   Register this Author

Register author
Odile Beyne-Rauzy

Odile Beyne-Rauzy

Publications by authors named "Odile Beyne-Rauzy"

Are you Odile Beyne-Rauzy?   Register this Author

61Publications

2236Reads

19Profile Views

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.

N Engl J Med 2020 01;382(2):140-151

From Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris (P.F., L.A.), Service des Maladies du Sang, Hôpital Huriez, Centre Hospitalier Universitaire (CHU) de Lille, Lille (B.Q.), the Department of Internal Medicine, CHU Toulouse, Institut Universitaire du Cancer de Toulouse, Toulouse (O.B.-R.), and Université Cote d'Azur, Département d'Hématologie Clinique, CHU Nice, Nice (T.C.) - all in France; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig (U.P.), Klinik für Hämatologie, Onkologie, and Klinische Immunologie, Universitätsklinik Düsseldorf, Düsseldorf (U.G.), and Klinik und Poliklinik für Innere Medizin III, Technische Universität München, Munich (K.S.G.) - all in Germany; the Department of Haemato-Oncology, King's College London, London (G.J.M.), Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford (P.V.), and the Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds (D.B.) - all in the United Kingdom; the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston (G.G.-M.); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto (R.B.); MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence (V.S.), the Department of Oncology and Hematology, S. Orsola-Malpighi University Hospital, Bologna (C.F.), the University of Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia (M.C.), the Hematology Unit, Santi Antonio e Biagio e Cesare Arrigo Hospital, Alessandria (F.S., V.G.), and Dipartimento Biomedicina e Prevenzione, University of Rome Tor Vergata, Rome (M.-T.V.) - all in Italy; the Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca, Salamanca (M.D.-C.), Unidad de Hematología, Hospital Universitario Virgen del Rocío, Seville (J.F.F.), and the Department of Hematology, Hospital Universitario Cruces, Vizcaya (B.A.) - all in Spain; the Department of Hematology Science, School of Medicine, Ankara University, Ankara, Turkey (O.I.); the Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland (M.A.S.); the Department of Hematology, Algemeen Ziekenhuis Sint-Jan, Bruges (D.S.), and Universitair Ziekenhuis Gent, Ghent (D.M.) - both in Belgium; the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (A.E.D.); the Division of Hematology-Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center (J.G.J.), and Albert Einstein College of Medicine (A.V.) - both in New York; the Department of Hematology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands (E.V.); Stanford University Cancer Center, Stanford, CA (P.L.G.); the Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm (E.H.-L.); the Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT (A.M.Z.); Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville (M.R.S.); Celgene, Summit, NJ (A.L., J.Z., A.R., D.R.D.); Celgene International, Boudry, Switzerland (A.B.); Acceleron Pharma, Cambridge, MA (P.G.L., M.L.S.); and Moffitt Cancer Center, Tampa, FL (R.S.K., A.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908892DOI Listing
January 2020

Nivolumab-induced eosinophilic fasciitis: a case report.

Rheumatol Adv Pract 2020 28;4(1):rkaa001. Epub 2020 Jan 28.

Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse Oncopole.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rap/rkaa001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010959PMC
January 2020

Small Private Online Course in Teaching Oncology-Feedback After 1 Year: What Lessons?

J Cancer Educ 2019 Aug 13. Epub 2019 Aug 13.

Université Paul Sabatier Toulouse III, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-019-01598-zDOI Listing
August 2019

Immune checkpoint inhibitor-related acral vasculitis.

J Immunother Cancer 2018 11 16;6(1):120. Epub 2018 Nov 16.

Service de Médecine Interne, Centre Hospitalier Universitaire Toulouse Purpan - Institut Universitaire du Cancer Toulouse Oncopole, 1 av Joliot-Curie, 31100, Toulouse, France.

View Article

Download full-text PDF

Source
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0
Publisher Site
http://dx.doi.org/10.1186/s40425-018-0443-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240222PMC
November 2018

The Impact of a Small Private Online Course as a New Approach to Teaching Oncology: Development and Evaluation.

JMIR Med Educ 2018 Mar 5;4(1):e6. Epub 2018 Mar 5.

Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/mededu.9185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859739PMC
March 2018

Effect of pregnancy in women with a history of primary immune thrombocytopenia considered as cured.

Eur J Intern Med 2017 Dec 26;46:e15-e16. Epub 2017 Aug 26.

Service de Médecine Interne, Institut Universitaire du Cancer de Toulouse Oncopole - CHU de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2017.08.023DOI Listing
December 2017

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

Validation of immune thrombocytopenia diagnosis code in the French hospital electronic database.

Eur J Intern Med 2016 Jul 21;32:e21-2. Epub 2016 Mar 21.

UMR 1027, INSERM, Faculté de Médecine, Université de Toulouse III, Toulouse, France; CIC 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2016.02.021DOI Listing
July 2016

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.

Blood 2016 Feb 1;127(6):749-60. Epub 2015 Dec 1.

Assistance Publique-Hôpitaux de Paris, Service d'Hématologie Biologique, Hôpitaux Universitaires Paris Centre, Paris, France; Institut Cochin, INSERM U1016, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Université Paris Descartes, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-04-640128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937206PMC
February 2016

Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network.

Am J Hematol 2014 Dec 20;89(12):E244-52. Epub 2014 Oct 20.

Département d'Hématologie-Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France; Service d'Hématologie, Hôpitaux Universitaires de Strasbourg, F-67098, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23848DOI Listing
December 2014

Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.

Am J Hematol 2011 Dec 28;86(12):980-4. Epub 2011 Sep 28.

Department of Internal Medicine, national referral center for adult's immune cytopenias, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22170DOI Listing
December 2011

[Myelodysplastic syndromes in adults].

Presse Med 2007 Mar 15;36(3 Pt 2):481-91. Epub 2006 Dec 15.

Service de Médecine Interne, Pavillon des Médecines, CHU Toulouse Purpan, TSA 40031.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2006.10.019DOI Listing
March 2007

Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells.

Blood 2005 Nov 14;106(9):3200-5. Epub 2005 Jul 14.

Institut National de la Santé et de la Recherche Médicale (INSERM) U563, Centre Hospitalier et Universitaire (CHU) Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-04-1386DOI Listing
November 2005

Anti-PCNA antibodies: prevalence and predictive value.

Joint Bone Spine 2005 Oct 22;72(5):432-5. Epub 2005 Mar 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2004.11.005DOI Listing
October 2005

Antileukemic activity of rapamycin in acute myeloid leukemia.

Blood 2005 Mar 18;105(6):2527-34. Epub 2004 Nov 18.

Institut National de la Santé et de la Recherche Médicale (Inserm) U563, CPTP, Département d'Oncogenèse et signalisation dans les cellules hématopoïétiques, IFR30, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-06-2494DOI Listing
March 2005

Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells.

Oncogene 2004 Sep;23(45):7507-16

Institut National de la Santé et de la Recherche Médicale U563, Centre de Physiopathologie de Toulouse Purpan, Place du Docteur Baylac, 31059, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208024DOI Listing
September 2004

Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis.

Cancer Res 2004 May;64(9):3191-7

Institut National de la Santé et de la Recherche Médicale Unité 563, Département d'Oncogenèse et Signalisation Cellulaire dans les Cellules Hématopoïétiques, Institut Fédératif de Recherche (IFR)30, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-3005DOI Listing
May 2004